Jyri Lommi

University of Helsinki — Finland

Medicine · Health Sciences

26h-index2.7kcitations103works6.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cardiac Valve Diseases and Treatments(20), Transplantation: Methods and Outcomes(17), Cardiovascular Function and Risk Factors(16), Renal Transplantation Outcomes and Treatments(10), Heart Failure Treatment and Management(9)

Publications101 total

High cholesterol absorption efficiency interferes with bile acid metabolism and cholesterol elimination from the body
Journal of Internal Medicine·2025Open Access
Donor Simvastatin Treatment in Heart Transplantation: 5-y Results of SIMVA Trial
Transplantation·2025· 3 citedOpen Access
Cardiac magnetic resonance in heart transplant recipients: histological, clinical and cell-free DNA validation
European Heart Journal - Cardiovascular Imaging·2025· 1 citedOpen Access
Cardiac Magnetic Resonance for Rejection Screening in Heart Transplant Recipients: Histological, Clinical, and Cell-Free DNA Validation
The Journal of Heart and Lung Transplantation·2025
Challenging endomyocardial biopsies' gold standard status in rejection screening: a prospective blinded study on cardiovascular magnetic resonance in heart transplant patients
European Heart Journal·2024Open Access
Randomized Trial of Cholesterol Lowering With Evolocumab for Cardiac Allograft Vasculopathy in Heart Transplant Recipients
JACC Heart Failure·2024· 19 citedOpen Access
Donor plasma VEGF-A as a biomarker for myocardial injury and primary graft dysfunction after heart transplantation
The Journal of Heart and Lung Transplantation·2024· 2 citedOpen Access
Impact of Atrial Fibrillation on the Symptoms and Echocardiographic Evaluation of Patients With Aortic Stenosis
The American Journal of Cardiology·2023· 6 citedOpen Access
Amiodarone accumulates two cholesterol precursors in myocardium: A controlled clinical study
Journal of Internal Medicine·2023· 3 citedOpen Access
Abstract 10250: Association of Nutritional Status With Symptoms and Quality of Life After Aortic Valve Replacement
Circulation·2022
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry
European Heart Journal - Quality of Care and Clinical Outcomes·2022· 42 citedOpen Access
Outcomes after coronary artery bypass grafting and percutaneous coronary intervention in diabetic and non-diabetic patients
European Heart Journal - Quality of Care and Clinical Outcomes·2021· 4 citedOpen Access
Peak flow measurements in patients with severe aortic stenosis: a prospective comparative study between cardiovascular magnetic resonance 2D and 4D flow and transthoracic echocardiography
Journal of Cardiovascular Magnetic Resonance·2021· 18 citedOpen Access
Global longitudinal strain in patients with severe aortic stenosis: a comparison between cardiac magnetic resonance imaging feature tracking and speckle tracking echocardiography
European Heart Journal - Cardiovascular Imaging·2021Open Access
Fulminantti myokardiitti vaatii nopeaa diagnosointia
Työväentutkimus Vuosikirja·2021Open Access
CMR 4D flow underestimates peak systolic flow measurements in patients with severe aortic stenosis
European Heart Journal - Cardiovascular Imaging·2021Open Access
Corrigendum to ‘Extracorporeal membrane oxygenation for refractory cardiogenic shock: patient survival and health-related quality of life’  [Eur J Cardiothorac Surg 2019;55:780-787]
European Journal of Cardio-Thoracic Surgery·2020Open Access
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De‐novo heart transplant recipients: Design of the randomized controlled EVOLVD trial
Clinical Transplantation·2020· 26 citedOpen Access
Clinical practice patterns in revascularization of diabetic patients with coronary heart disease: nationwide register study
Annals of Medicine·2020· 5 citedOpen Access
Amiodarone disrupts cholesterol biosynthesis pathway and causes accumulation of circulating desmosterol by inhibiting 24‐dehydrocholesterol reductase
Journal of Internal Medicine·2020· 19 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Markku Kupari(25), Heikki Turto(17), Kalervo Werkkala(10), Petri T. Kovanen(10), Karl Lemström(10), Satu Helske(9), Ken A. Lindstedt(6), Mika Laine(6), Ari Harjula(6), Suvi Syväranta(5), Janne J. Jokinen(5), Mikko I. Mäyränpää(4), L Gullestad(4), Anne Räisänen‐Sokolowski(3), Matti Härkönen(3), Jani Lappalainen(3), Markku O. Pentikäinen(3), Pekka Hämmäinen(3), J Sipponen(3), Salla Jäämaa‐Holmberg(3)